A genome-wide RNAi screen reveals common host-virus gene signatures: Implication for dengue antiviral drug discovery Journal Article


Authors: Shum, D.; Bhinder, B.; Mahida, J.; Radu, C.; Calder, P. A.; Djaballah, H.
Article Title: A genome-wide RNAi screen reveals common host-virus gene signatures: Implication for dengue antiviral drug discovery
Abstract: Dengue is the most common mosquito-borne viral disease that in recent years has become a major international public health concern. Dengue is a tropical neglected disease with increasing global incidences, affecting millions of people worldwide, and without the availability of specific treatments to combat it. The identification of host-target genes essential for the virus life cycle, for which effective modulators may already exist, would provide an alternative path to a rapid drug development of the much needed antidengue agents. For this purpose, we performed the first genome-wide RNAi screen, combining two high-content readouts for dengue virus infection (DENV E infection intensity) and host cell toxicity (host cell stained nuclei), against an arrayed lentiviral-based short hairpin RNA library covering 16,000 genes with a redundancy of at least 5 hairpins per gene. The screen identified 1924 gene candidates in total; of which, 1730 gene candidates abrogated dengue infection, whereas 194 gene candidates were found to enhance its infectivity in HEK293 cells. A first pass clustering analysis of hits revealed a well-orchestrated gene-network dependency on host cell homeostasis and physiology triggering distinct cellular pathways for infectivity, replication, trafficking, and egress; a second analysis revealed a comprehensive gene signature of 331 genes common to hits identified in 28 published RNAi host-viral interaction screens. Taken together, our findings provide novel antiviral molecular targets with the potential for drug discovery and development.
Keywords: core protein; infection; liver; egfr; cells; activation; pathway; replication; mitochondrial; entry
Journal Title: Gen Biotechnology
Volume: 2
Issue: 2
ISSN: 2768-1572
Publisher: Mary Ann Liebert, Inc  
Date Published: 2023-04-01
Start Page: 133
End Page: 148
Language: English
ACCESSION: WOS:001136593200005
DOI: 10.1089/genbio.2023.0001
PROVIDER: wos
PMCID: PMC10623629
PUBMED: 37928776
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bhavneet Bhinder
    31 Bhinder
  2. Hakim Djaballah
    101 Djaballah
  3. Constantin Radu
    28 Radu
  4. David Shum
    54 Shum
  5. Paul A Calder
    15 Calder
  6. Jeni P Mahida
    6 Mahida